Kenvue Inc.
KVUEAPI behind this page
KVUE FY 2025 request
Playground key active
/api/financials?ticker=KVUE&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue | 15,124 | 15,455 | -2.1% |
Show Business Segments breakouts |
|||
| Essential Health | 4,632 | 4,688 | -1.2% |
| Self Care | 6,378 | 6,527 | -2.3% |
| Skin Health and Beauty | 4,114 | 4,240 | -3.0% |
Show Geography breakouts |
|||
| Asia Pacific | 2,775 | 2,974 | -6.7% |
| EMEA | 3,721 | 3,559 | +4.6% |
| Latin America | 1,369 | 1,343 | +1.9% |
| North America | 7,259 | 7,579 | -4.2% |
| US | 6,460 | 6,719 | -3.9% |
| Cost of Revenue | 6,332 | 6,496 | -2.5% |
Show Counterparty Name breakouts |
|||
| Johnson & Johnson | 168 | 203 | -17.2% |
Show Restructuring Plan breakouts |
|||
| 2024 Multi-Year Restructuring Initiative | 36 | 27 | +33.3% |
| Gross Profit | 8,792 | 8,959 | -1.9% |
| Selling, General & Administrative | 6,088 | 6,329 | -3.8% |
Show Product Lines breakouts |
|||
| Shipping And Handling | 482 | 505 | -4.6% |
Show Restructuring Plan breakouts |
|||
| 2024 Multi-Year Restructuring Initiative | 9 | 9 | 0.0% |
| Restructuring Charges | 290 | 185 | +56.8% |
Show Restructuring Plan breakouts |
|||
| 2024 Multi-Year Restructuring Initiative | 290 | 185 | +56.8% |
| Asset Impairment Charges | 23 | 578 | -96.0% |
| Other Operating Income Expense Net | -23 | 26 | -188.5% |
| Operating Income | 2,414 | 1,841 | +31.1% |
| Non-Operating Income (Expense) | 36 | 48 | -25.0% |
| Interest Income Expense Nonoperating Net | 379 | 378 | +0.3% |
| Income Before Taxes | 1,999 | 1,415 | +41.3% |
| Income Tax Expense (Benefit) | 529 | 385 | +37.4% |
| Net Income | 1,470 | 1,030 | +42.7% |
Show Equity Components breakouts |
|||
| Retained Earnings | 1,470 | 1,030 | +42.7% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 20 | 17 | +17.6% |
Show Related Party Transaction breakouts |
|||
| Net Economic Benefit Arrangements · Parent | 28 | 51 | -45.1% |
| EPS (Basic) | 0.77 | 0.54 | +42.6% |
| EPS (Diluted) | 0.76 | 0.54 | +40.7% |
| Wtd Avg Shares (Basic) | 1,917 | 1,915 | +0.1% |
| Wtd Avg Shares (Diluted) | 1,924 | 1,923 | +0.1% |
| Research & Development | 382 | 408 | -6.4% |
| Other Non-Operating Income (Expense) | -10 | -4 | -150.0% |
| Comprehensive Income | 2,657 | 261 | +918.0% |
| Other Comprehensive Income | 1,187 | -769 | +254.4% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | 5 | 37 | -86.5% |
| Accumulated Other Comprehensive Income | 1,187 | -769 | +254.4% |
| Accumulated Translation Adjustment | 1,178 | -783 | +250.4% |
| Gain (Loss) on Derivatives and Hedges | 4 | -23 | +117.4% |
| Foreign Currency Transaction Gain Loss Before Tax | 41 | 7 | +485.7% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,062 | 1,070 | -0.7% |
| Accounts Receivable | 2,382 | 2,165 | +10.0% |
| Inventory | 1,666 | 1,591 | +4.7% |
| Prepaid Expenses & Other Current Assets | 432 | 494 | -12.6% |
Show Counterparty Name breakouts |
|||
| Johnson & Johnson | 21 | 109 | -80.7% |
| Other Assets Current | 155 | 205 | -24.4% |
| Total Current Assets | 5,697 | 5,525 | +3.1% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,212 | 1,849 | +19.6% |
| Goodwill | 9,509 | 8,843 | +7.5% |
Show Business Segments breakouts |
|||
| Essential Health | 1,684 | 1,604 | +5.0% |
| Self Care | 5,562 | 5,054 | +10.1% |
| Skin Health and Beauty | 2,263 | 2,185 | +3.6% |
| Deferred Tax Assets | 237 | 184 | +28.8% |
| Other Non-Current Assets | 727 | 726 | +0.1% |
Show Counterparty Name breakouts |
|||
| Johnson & Johnson | 91 | 78 | +16.7% |
| Total Assets | 27,076 | 25,601 | +5.8% |
| Operating Lease Right-of-Use Assets | 151 | 111 | +36.0% |
Show Counterparty Name breakouts |
|||
| Johnson & Johnson | 26 | 35 | -25.7% |
Show Balance Sheet Location breakouts |
|||
| Other Assets | 151 | 111 | +36.0% |
| Intangible Assets | 3,792 | 3,771 | +0.6% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 871 | 859 | +1.4% |
| Other Intangible Assets | 569 | 582 | -2.2% |
| Patents and trademarks | 2,352 | 2,330 | +0.9% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 8,694 | 8,474 | +2.6% |
Show Indefinite Lived Intangible Assets By Major Class breakouts |
|||
| Other Intangible Assets | 62 | 55 | +12.7% |
| Trademarks | 4,840 | 4,648 | +4.1% |
| Current Liabilities | |||
| Debt Current | 1,453 | 1,552 | -6.4% |
| Accounts Payable | 2,473 | 2,254 | +9.7% |
Show Related Party Transaction breakouts |
|||
| Net Economic Benefit Arrangements · Parent | 44 | 23 | +91.3% |
| Accrued Liabilities | 1,159 | 1,132 | +2.4% |
| Accrued Rebates Returns And Promotions Current | 755 | 727 | +3.9% |
| Accrued Income Taxes Current | 105 | 74 | +41.9% |
| Total Current Liabilities | 5,945 | 5,739 | +3.6% |
| Commercial Paper | 700 | 800 | -12.5% |
| Current Portion of Long-Term Debt | -750 | -750 | 0.0% |
| Non-Current Liabilities | |||
| Deferred Tax Liabilities | 2,354 | 2,261 | +4.1% |
| Employee Related Liabilities Current And Noncurrent | 340 | 342 | -0.6% |
| Other Non-Current Liabilities | 601 | 536 | +12.1% |
Show Counterparty Name breakouts |
|||
| Johnson & Johnson | 139 | 143 | -2.8% |
| Total Liabilities | 16,311 | 15,933 | +2.4% |
| Operating Lease Liabilities | 107 | 76 | +40.8% |
Show Counterparty Name breakouts |
|||
| Johnson & Johnson | 15 | 24 | -37.5% |
Show Balance Sheet Location breakouts |
|||
| Other Noncurrent Liabilities | 107 | 76 | +40.8% |
| Accrued Income Taxes Noncurrent | 219 | 185 | +18.4% |
| Other Liabilities | |||
| Long Term Debt And Lease Obligation Excluding Current Maturities | 7,071 | 7,055 | +0.2% |
| Stockholders' Equity | |||
| Common Stock | 19 | 19 | 0.0% |
| Additional Paid-In Capital | 16,348 | 16,130 | +1.4% |
| Treasury Stock Common Value | -439 | -242 | -81.4% |
| Retained Earnings | -204 | -93 | -119.4% |
| Accumulated Other Comprehensive Income | -4,959 | -6,146 | +19.3% |
| Total Stockholders' Equity | 10,765 | 9,668 | +11.3% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -125 | -130 | +3.8% |
| Accumulated Other Comprehensive Income | -4,959 | -6,146 | +19.3% |
| Accumulated Translation Adjustment | -4,862 | -6,040 | +19.5% |
| Additional Paid In Capital | 16,348 | 16,130 | +1.4% |
| Common Stock | 19 | 19 | 0.0% |
| Gain (Loss) on Derivatives and Hedges | 28 | 24 | +16.7% |
| Retained Earnings | -204 | -93 | -119.4% |
| Treasury Stock Common | -439 | -242 | -81.4% |
| Total Liabilities & Equity | 27,076 | 25,601 | +5.8% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 557 | 622 | -10.5% |
Show Business Segments breakouts |
|||
| Essential Health | 230 | 231 | -0.4% |
| Self Care | 204 | 217 | -6.0% |
| Skin Health and Beauty | 123 | 174 | -29.3% |
| Stock-Based Compensation | 136 | 254 | -46.5% |
| Deferred Income Taxes | -108 | -285 | +62.1% |
| Other Non-Cash Items | 67 | 69 | -2.9% |
| Change in Accounts Receivable | -112 | -218 | +48.6% |
| Change in Inventory | -12 | 182 | -106.6% |
| Increase Decrease In Other Operating Assets | 122 | -17 | +817.6% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 41 | -536 | +107.6% |
| Increase Decrease In Employee Related Liabilities | 43 | 27 | +59.3% |
| Increase Decrease In Accrued Taxes Payable | -27 | -61 | +55.7% |
| Increase Decrease In Other Operating Liabilities | -3 | 52 | -105.8% |
| Net Cash from Operations | 2,197 | 1,769 | +24.2% |
| Investing Activities | |||
| Capital Expenditures | -475 | -434 | -9.4% |
| Costs Associated With Proceeds From Sale Of Assets Investing Activities | 24 | -6 | +500.0% |
| Other Investing Activities | 15 | 15 | 0.0% |
| Net Cash from Investing | -436 | -425 | -2.6% |
| Financing Activities | |||
| Proceeds From Repayments Of Commercial Paper | -146 | 157 | -193.0% |
| Proceeds From Issuance Of Unsecured Debt | 746 | — | — |
| Repayments Of Senior Debt | -750 | — | — |
| Payments Of Dividends | -1,581 | -1,552 | -1.9% |
| Share Repurchases | -197 | -235 | +16.2% |
| Proceeds From Payments For Other Financing Activities | 91 | 65 | +40.0% |
| Net Cash from Financing | -1,837 | -1,565 | -17.4% |
| Supplemental | |||
| Income Taxes Paid | 595 | 810 | -26.5% |
| Interest Paid | 440 | 439 | +0.2% |
| Income Taxes Paid | 595 | — | — |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 68 | -91 | +174.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,062 | 1,070 | -0.7% |
| Net Change in Cash | -8 | -312 | +97.4% |
Values in millions USD. Source: SEC EDGAR 10-K filing.